Researcher Publication Search

Name: Anne Fagan
Year: 2015

Reference:

Fagan AM. What does it mean to be ‘amyloid-positive’? Brain. 2015 Mar;138(Pt 3):514-6. PMCID: PMC4408431

Name: Anne Fagan
Year: 2015

Reference:

Fleisher AS, Chen K, Quiroz YT, Jakimovich LJ, Gutierrez Gomez M, Langois CM, Langbaum JB, Roontiva A, Thiyyagura P, Lee W, Ayutyanont N,Lopez L, Moreno S, Muñoz C, Tirado V, Acosta-Baena N, Fagan AM, Giraldo M, Garcia G, Huentelman MJ, Tariot PN, Lopera F, Reiman EM. Associations Between Biomarkers and Age in the Presenilin 1 E280A Autosomal Dominant Alzheimer Disease Kindred: A Cross-sectional Study. JAMA Neurol. 2015 Mar;72(3):316-24. PMCID: PMC4355261

Name: Anne Fagan
Year: 2015

Reference:

Gordon BA, Zacks JM, Blazey T, Benzinger TL, Morris JC, Fagan AM, Holtzman DM, Balota DA. Task-evoked fMRI changes in attention networks are associated with preclinical Alzheimer’s disease biomarkers. Neurobiol Aging. 2015 May; 36(5):1771-9. PMCID: PMC4417039

Name: david balota
Year: 2015

Reference:

Gordon BA, Zacks JM, Blazey T, Benzinger TLS, Morris JC, Fagan AM, Holtzman DM, Balota DA. Task-evoked fMRI Changes in Attention Networks are Associated with Preclinical Alzheimer’s Disease Biomarkers. Neurobiology of Aging 2015; 36: 1771-1779. PMCID: PMC4417039.

Name: Brian Gordon
Year: 2015

Reference:

Gordon, BA, Najmi, S, Hsu, P, Benzinger, TLS (2015) The effects of white matter hyperintensities and amyloid in Alzheimer’s disease. NeuroImage Clinical. 8:246-252 doi:10.1016/j.nicl.2015.04.017

Name: Brian Gordon
Year: 2015

Reference:

Gordon, BA, Zacks, J, Blazey, T, Benzinger, TLS, Morris, JC, Fagan, AM, Holtzman, DM, Balota, DA. (2015) Task-evoked fMRI Changes in Attention Networks are Associated with Preclinical Alzheimer Disease Biomarkers. Neurobiology of Aging. 36(5): 1771-1779 PMC4417039

Name: Nigel Cairns
Year: 2015

Reference:

Hassenstab J, Monsell SE, Mock C, Roe CM, Cairns NJ, Morris JC, Kukull W. Neuropsychological Markers of Cognitive Decline in Persons With Alzheimer Disease Neuropathology.J Neuropathol Exp Neurol. 2015 Nov;74(11):1086-92. NIHMS717503

Name: Jason Hassenstab
Year: 2015

Reference:

Hassenstab J, Ruvolo D, Jasielec M, Xiong C, Grant E, Morris JC. Absence of practice effects in preclinical Alzheimer’s disease. Neuropsychology 2015 May 25. Epub ahead of print. PMID: 26011114

Name: Nigel Cairns
Year: 2015

Reference:

Hortobagyi T and Cairns NJ. Amyotrophic lateral sclerosis and frontotemporal lobar degeneration. In G. Kovacs (editor) Neuropathology of Neurodegenerative Diseases: A Practical Guide. Cambridge University Press, Cambridge, UK, 2015, pp 209-248.

Name: david balota
Year: 2015

Reference:

Huff MJ, Balota DA, Minear M, Aschenbrenner AJ, Duchek JM. Dissociative global and local task-switching costs across younger adults, middle-aged adults, older adults, and very mild Alzheimer’s disease individuals. Psychology and Aging; 30: 727-739. PMCID: PMC4681312.

Name: Andrew Aschenbrenner
Year: 2015

Reference:

Huff, M. J., Balota, D. A., Minear, M., Aschenbrenner, A. J., & Duchek, J. M. (in press). Dissociative global and local task-switching costs across young adults, older adults, and very mild Alzheimer disease individuals. Psychology and Aging

Name: Anne Fagan
Year: 2015

Reference:

Jansen WJ, Ossenkoppele R, Knol DL, Tijms BM, Scheltens P, Verhey FR, Visser PJ; Amyloid Biomarker Study Group, Aalten P, Aarsland D, Alcolea D,Alexander M, Almdahl IS, Arnold SE, Baldeiras I, Barthel H, van Berckel BN, Bibeau K, Blennow K, Brooks DJ, van Buchem MA, Camus V, Cavedo E, Chen K,Chetelat G, Cohen AD, Drzezga A, Engelborghs S, Fagan AM, Fladby T, Fleisher AS, van der Flier WM, Ford L, Forster S, Fortea J, Foskett N, Frederiksen KS,Freund-Levi Y, Frisoni GB, Froelich L, Gabryelewicz T, Gill KD, Gkatzima O, Gomez-Tortosa E, Gordon MF, Grimmer T, Hampel H, Hausner L, Hellwig S,Herukka SK, Hildebrandt H, Ishihara L, Ivanoiu A, Jagust WJ, Johannsen P, Kandimalla R, Kapaki E, Klimkowicz-Mrowiec A, Klunk WE, Kohler S, Koglin N,Kornhuber J, Kramberger MG, Van Laere K, Landau SM, Lee DY, de Leon M, Lisetti V, Lleo A, Madsen K, Maier W, Marcusson J, Mattsson N, de Mendonca A,Meulenbroek O, Meyer PT, Mintun MA, Mok V, Molinuevo JL, Mollergard HM, Morris JC, Mroczko B, Van der Mussele S, Na DL, Newberg A, Nordberg A,Nordlund A, Novak GP, Paraskevas GP, Parnetti L, Perera G, Peters O, Popp J, Prabhakar S, Rabinovici GD, Ramakers IH, Rami L, Resende de Oliveira C,Rinne JO, Rodrigue KM, Rodriguez-Rodriguez E, Roe CM, Rot U, Rowe CC, Ruther E, Sabri O, Sanchez-Juan P, Santana I, Sarazin M, Schroder J, Schutte C,Seo SW, Soetewey F, Soininen H, Spiru L, Struyfs H, Teunissen CE, Tsolaki M, Vandenberghe R, Verbeek MM, Villemagne VL, Vos SJ, van Waalwijk van Doorn LJ, Waldemar G, Wallin A, Wallin AK, Wiltfang J, Wolk DA, Zboch M, Zetterberg H. Prevalence of cerebral amyloid pathology in persons without dementia: a meta-analysis. JAMA. 2015 May 19;313(19):1924-38. PMCID: PMC4486209

Name: Anne Fagan
Year: 2015

Reference:

Kester MI, Teunissen CE, Crimmins DL, Herries EM, Ladenson JH, Scheltens P, van der Flier WM, Morris JC, Holtzman DM, Fagan AM.. Neurogranin as a Cerebrospinal Fluid Biomarker for Synaptic Loss in Symptomatic Alzheimer Disease. JAMA Neurol. 2015 Sep 14:1-7. PMCID:PMC4694558

Name: Anne Fagan
Year: 2015

Reference:

Kim A, Fagan AM, Goate AM, Benzinger TL, Morris JC, Head D; Alzheimer’s Disease Neuroimaging Initiative. Lack of an association of BDNF Val66Met polymorphism and plasma BDNF with hippocampal volume and memory. Cogn Affect Behav Neurosci. 2015 Mar 18. PMCID: PMC4529376

Name: Tammie Benzinger
Year: 2015

Reference:

Klunk WE, Koeppe RA, Price JC, Benzinger TL, Devous MD, Sr., Jagust WJ, Johnson KA, Mathis CA, Minhas D, Pontecorvo MJ, Rowe CC, Skovronsky DM, Mintun MA. The Centiloid Project: Standardizing quantitative amyloid plaque estimation by PET. Alzheimer’s & dementia : the journal of the Alzheimer’s Association. 2015;11(1):1-15.e4. Epub 2014/12/03. doi: 10.1016/j.jalz.2014.07.003. PubMed PMID: 25443857; PubMed Central PMCID: PMC4300247.

Name: david balota
Year: 2015

Reference:

Kotyuk E, Duchek JM, Head D, Szekely A, Goate AM, Balota DA. A genetic variant COMT coding dopaminergic activity predicts personality traits in healthy elderly. Personality and Individual Differences 2015; 82: 61-66. PMCID: PMC4422069.

Name: Anne Fagan
Year: 2015

Reference:

Leung YY, Toledo JB, Nefedov A, Polikar R, Raghavan N, Xie SX, Farnum M, Schultz T, Baek Y, Deerlin VV, Hu WT, Holtzman DM, Fagan AM, Perrin RJ, Grossman M, Soares HD, Kling MA, Mailman M, Arnold SE, Narayan VA, Lee VM, Shaw LM, Baker D, Wittenberg GM, Trojanowski JQ, Wang LS. Identifying amyloid pathology-related cerebrospinal fluid biomarkers for Alzheimer’s disease in a multicohort study. Alzheimers Dement (Amst). 2015 Sep 1;1(3):339-348. PMCID: PMC4672388

Name: Brendan Lucey
Year: 2015

Reference:

Lucey BP, Gonzales C, Das U, Li J, Siemers ER, Slemmon JR, Bateman RJ, Huang Y, Fox GB, Claassen JA, Slats D, Verbeek MM, Tong G, Soares H, Savage MJ, Kennedy M, Forman M, Sjögren M, Margolin R, Chen X, Farlow MR, Dean RA, Waring JF. An integrated multi-study analysis of intra-subject variability in cerebrospinal fluid amyloid-β concentrations collected by lumbar puncture and indwelling lumbar catheter. Alzheimers Res Ther. 2015 Jul 29;7(1):53. PMID: 26225140. PMCID: PMC4518529

Name: Shannon Macauley-Rambach
Year: 2015

Reference:

Macauley SL, Holtzman DM. Recent Advances from the Bench Toward the Bedside in Alzheimer’s Disease. EBioMedicine. 2015 Jan 9;2(2):94-5. doi: 10.1016/j.ebiom.2015.01.002. eCollection 2015 Feb. No abstract available. PMID: 26137544

Name: Shannon Macauley-Rambach
Year: 2015

Reference:

Macauley SL, Stanley M, Caesar EE, Yamada SA, Raichle ME, Perez R, Mahan TE, Sutphen CL, Holtzman DM. Hyperglycemia modulates extracellular amyloid-β concentrations and neuronal activity in vivo. J Clin Invest. 2015 Jun;125(6):2463-7. doi: 10.1172/JCI79742. Epub 2015 May 4.
PMID: 25938784

Name: david balota
Year: 2015

Reference:

Maddox GB, Balota DA. Retrieval practice and spacing effects in and young and older adults: An examination of the benefits of desirable difficulty. Memory & Cognition 2015; 45, 5: 760-774. PMCID: PMC4480221.

Name: Anne Fagan
Year: 2015

Reference:

Monserrate AE, Ryman DC, Ma S, Xiong C, Noble JM, Ringman JM, Morris JC, Danek A, Muller-Sarnowski F, Clifford DB, McDade EM, Brooks WS, Darby DG, Masters CL, Weston PS, Farlow MR, Graff-Radford NR, Salloway SP, Fagan AM, Oliver A, Bateman RJ; for the Dominantly Inherited Alzheimer Network. Factors Associated with the Onset and Persistence of Post-Lumbar Puncture Headache. JAMA Neurol. 2015 Mar;72(3):325-32. PMCID: PMC4364538

Name: Anne Fagan
Year: 2015

Reference:

Quiroz YT, Schultz AP, Chen K, Protas HD, Brickhouse M, Fleisher AS, Langbaum JB, Thiyyagura P, Fagan AM, Shah AR, Muniz M, Arboleda-Velasquez JF, Munoz C, Garcia G, Acosta-Baena N, Giraldo M, Tirado V, Ramírez DL, Tariot PN, Dickerson BC, Sperling RA, Lopera F, Reiman EM. Brain Imaging and Blood Biomarker Abnormalities in Children with Autosomal Dominant Alzheimer Disease: A Cross-Sectional Study. JAMA Neurol. 2015 Aug;72(8):912-9. PMCID: PMC4625544

Name: Anne Fagan
Year: 2015

Reference:

Schindler SE and Fagan AM. Autosomal dominant Alzheimer disease: a unique resource to study CSF biomarker changes in preclinical AD. Frontiers in Neurology, 2015, Jun 29;6:142. doi: 10.3389/fneur.2015.00142. eCollection 2015. Review. PMCID: PMC4483518

Name: Suzanne Schindler
Year: 2015

Reference:

Schindler SE, Fagan AM. Autosomal Dominant Alzheimer Disease: A Unique Resource to Study CSF Biomarker Changes in Preclinical AD. Front Neurol 2015; 6:142. PMID: 26175713.